[Form 4] ZIMMER BIOMET HOLDINGS, INC. Insider Trading Activity
Insider transaction disclosed for ZIMMER BIOMET HOLDINGS, INC. (ZBH). The reporting person, Sang Yi, Group President, Asia Pacific and an officer and director, reported a sale of 1,200 shares of common stock on 09/11/2025 at a price of $103.585 per share. After the sale, the filing shows 18,584 shares beneficially owned by the reporting person. The filing also notes that the reported beneficial ownership includes 160 shares acquired under the Employee Stock Purchase Plan on June 30, 2025. The Form 4 was signed by an attorney-in-fact on 09/15/2025.
Transazione insider divulgata per ZIMMER BIOMET HOLDINGS, INC. (ZBH). La persona che segnala, Sang Yi, Group President, Asia Pacific e un dirigente e amministratore, ha riportato una vendita di 1.200 azioni ordinarie in data 09/11/2025 al prezzo di $103,585 per azione. Dopo la vendita, la documentazione mostra che 18.584 azioni sono possedute beneficiariamente dalla persona che segnala. La documentazione osserva anche che la proprietà beneficamente riportata include 160 azioni acquisite ai sensi del Employee Stock Purchase Plan il 30 giugno 2025. Il Form 4 è stato firmato da un procuratore-in-fatto in data 09/15/2025.
Transacción de insider divulgada para ZIMMER BIOMET HOLDINGS, INC. (ZBH). La persona que reporta, Sang Yi, President del Grupo, Asia Pacífico y un directivo y director, reportó la venta de 1.200 acciones de acciones comunes en la fecha 09/11/2025 a un precio de $103.585 por acción. Después de la venta, el archivo muestra que 18.584 acciones son poseídas beneficiosamente por la persona que reporta. El archivo también señala que la propiedad beneficiosa reportada incluye 160 acciones adquiridas bajo el Employee Stock Purchase Plan el 30 de junio de 2025. El Form 4 fue firmado por un apoderado en fecha 09/15/2025.
ZIMMER BIOMET HOLDINGS, INC. (ZBH)에 대한 내부자 거래 공시. 보고 당사자는 Sang Yi, Asia Pacific 그룹 사장 겸 임원 및 이사로서 2025년 9월 11일 주당 103.585달러의 가격으로 보통주 1,200주를 매도했다고 보고했습니다. 매도 후 보고서에는 18,584주의 주식을 실질적으로 소유하고 있는 것으로 나타납니다. 보고서에는 또한 보고된 실질 소유가 2025년 6월 30일에 직원 주식 매입 계획을 통해 취득한 160주를 포함한다는 점도 명시되어 있습니다. Form 4는 2025년 9월 15일에 대리인이 서명했습니다.
Transaction d'initié divulguée pour ZIMMER BIOMET HOLDINGS, INC. (ZBH). La personne déclarante, Sang Yi, président du groupe Asie-Pacifique et cadre et administrateur, a signalé une vente de 1 200 actions ordinaires le 09/11/2025 au prix de 103,585 $ par action. Après la vente, le dépôt indique 18 584 actions détenues bénéficiairement par la personne déclarant. Le dépôt précise également que la propriété bénéficiaire déclarée comprend 160 actions acquises dans le cadre du Employee Stock Purchase Plan le 30 juin 2025. Le Formulaire 4 a été signé par un procureur le 15/09/2025.
Insider-Verkauf disclosed für ZIMMER BIOMET HOLDINGS, INC. (ZBH). Die meldende Person, Sang Yi, Gruppenpräsident, Asien-Pazifik, und ein Vorstandsmitglied berichtete über den Verkauf von 1.200 Stammaktien am 11.09.2025 zu einem Preis von 103,585 $ pro Aktie. Nach dem Verkauf zeigt die Einreichung, dass 18.584 Aktien von der meldenden Person vorteilhaft besessen werden. Die Einreichung vermerkt auch, dass der gemeldete vorteilhafte Besitz 160 Aktien umfasst, die im Employee Stock Purchase Plan am 30. Juni 2025 erworben wurden. Das Formular 4 wurde am 15.09.2025 von einem Bevollmächtigten unterschrieben.
إفصاح عن صفقة داخلية لشركة ZIMMER BIOMET HOLDINGS, INC. (ZBH). أشارت جهة الإبلاغ، سانغ يي، رئيس المجموعة لمنطقة آسيا والمحيط الهادئ، وموظف ومدير، إلى بيع 1,200 سهم من الأسهم العادية في 11/09/2025 بسعر 103.585 دولار للسهم. بعد البيع، تُظهر الوثيقة أن 18,584 سهماً مملوكة بشكل مستفيد من قِبل الشخص المبلغ. كما تشير الوثيقة إلى أن الملكية المستفاد منها تتضمن 160 سهماً اشتُتِيت بموجب خطة شراء أسهم الموظفين في 30 يونيو 2025. تم توقيع النموذج 4 من قبل وكيل مفوض في 15/09/2025.
披露的内部交易，涉及 ZIMMER BIOMET HOLDINGS, INC.（ZBH）。 报告人 Sang Yi，亚太区集团总裁，同时为官员兼董事，报告于 2025/09/11 以每股 103.585 美元价格出售了 1,200 股普通股。出售后，备案显示该报告人实际拥有 18,584 股。备案还指出，所述实际控制权包括 2025 年 6 月 30 日通过员工股票购买计划取得的 160 股。Form 4 于 2025/09/15 由委托律师签署。
- Complete transaction disclosure including date, price, quantity, and resulting beneficial ownership
- ESPP purchase disclosure showing 160 shares acquired on June 30, 2025 included in total ownership
- Form signed under power of attorney, indicating procedural compliance
- Insider sale of 1,200 shares which reduces the reporting person\'s holdings to 18,584 shares
- No statement of a 10b5-1 plan or reason for the sale is provided in the filing
Insights
TL;DR: Officer sold a small block of shares; ownership remains material but transaction appears routine.
The sale of 1,200 shares at $103.585 reduces the reporting person\'s stake to 18,584 shares. The filing explicitly records a June 30 ESPP purchase of 160 shares. This is a standard Section 16 disclosure showing a single non-derivative sale by an officer/director. There is no information in the filing about the reason for the sale, any 10b5-1 plan, or any related change to employment or control. For investors, the item is a routine insider sale rather than a corporate event.
TL;DR: Disclosure is complete for the transaction; no indication of governance issues in this filing.
The Form 4 identifies the reporting person\'s roles and provides transaction details: date, transaction code (S for sale), quantity, price, and resulting beneficial ownership. It also discloses the inclusion of ESPP-acquired shares. The signature is via a previously filed power of attorney. The document contains the required elements for transparency under Section 16 but does not indicate any material governance actions or policy changes.
Transazione insider divulgata per ZIMMER BIOMET HOLDINGS, INC. (ZBH). La persona che segnala, Sang Yi, Group President, Asia Pacific e un dirigente e amministratore, ha riportato una vendita di 1.200 azioni ordinarie in data 09/11/2025 al prezzo di $103,585 per azione. Dopo la vendita, la documentazione mostra che 18.584 azioni sono possedute beneficiariamente dalla persona che segnala. La documentazione osserva anche che la proprietà beneficamente riportata include 160 azioni acquisite ai sensi del Employee Stock Purchase Plan il 30 giugno 2025. Il Form 4 è stato firmato da un procuratore-in-fatto in data 09/15/2025.
Transacción de insider divulgada para ZIMMER BIOMET HOLDINGS, INC. (ZBH). La persona que reporta, Sang Yi, President del Grupo, Asia Pacífico y un directivo y director, reportó la venta de 1.200 acciones de acciones comunes en la fecha 09/11/2025 a un precio de $103.585 por acción. Después de la venta, el archivo muestra que 18.584 acciones son poseídas beneficiosamente por la persona que reporta. El archivo también señala que la propiedad beneficiosa reportada incluye 160 acciones adquiridas bajo el Employee Stock Purchase Plan el 30 de junio de 2025. El Form 4 fue firmado por un apoderado en fecha 09/15/2025.
ZIMMER BIOMET HOLDINGS, INC. (ZBH)에 대한 내부자 거래 공시. 보고 당사자는 Sang Yi, Asia Pacific 그룹 사장 겸 임원 및 이사로서 2025년 9월 11일 주당 103.585달러의 가격으로 보통주 1,200주를 매도했다고 보고했습니다. 매도 후 보고서에는 18,584주의 주식을 실질적으로 소유하고 있는 것으로 나타납니다. 보고서에는 또한 보고된 실질 소유가 2025년 6월 30일에 직원 주식 매입 계획을 통해 취득한 160주를 포함한다는 점도 명시되어 있습니다. Form 4는 2025년 9월 15일에 대리인이 서명했습니다.
Transaction d'initié divulguée pour ZIMMER BIOMET HOLDINGS, INC. (ZBH). La personne déclarante, Sang Yi, président du groupe Asie-Pacifique et cadre et administrateur, a signalé une vente de 1 200 actions ordinaires le 09/11/2025 au prix de 103,585 $ par action. Après la vente, le dépôt indique 18 584 actions détenues bénéficiairement par la personne déclarant. Le dépôt précise également que la propriété bénéficiaire déclarée comprend 160 actions acquises dans le cadre du Employee Stock Purchase Plan le 30 juin 2025. Le Formulaire 4 a été signé par un procureur le 15/09/2025.
Insider-Verkauf disclosed für ZIMMER BIOMET HOLDINGS, INC. (ZBH). Die meldende Person, Sang Yi, Gruppenpräsident, Asien-Pazifik, und ein Vorstandsmitglied berichtete über den Verkauf von 1.200 Stammaktien am 11.09.2025 zu einem Preis von 103,585 $ pro Aktie. Nach dem Verkauf zeigt die Einreichung, dass 18.584 Aktien von der meldenden Person vorteilhaft besessen werden. Die Einreichung vermerkt auch, dass der gemeldete vorteilhafte Besitz 160 Aktien umfasst, die im Employee Stock Purchase Plan am 30. Juni 2025 erworben wurden. Das Formular 4 wurde am 15.09.2025 von einem Bevollmächtigten unterschrieben.
FAQ
What did Sang Yi report in the Form 4 for ZBH?
How many shares does Sang Yi own after the reported transaction?
Were any shares recently acquired by Sang Yi disclosed?
When was the Form 4 signed and by whom?
Does the filing indicate a 10b5-1 trading plan for the sale?
